Literature DB >> 28561715

Endometrial Cancer: Is This a New Disease?

Kathleen Moore1, Molly A Brewer1.   

Abstract

The incidence of endometrial cancer is increasing, and the age of onset is younger than in prior years. Although endometrial cancer still occurs more commonly in older women, for whom the mortality rate is increasing, it also is being diagnosed in younger and younger women. The underlying cause of the increase in incidence is the epidemic of obesity and the resulting hyperinsulinemia. Conservative treatment may be indicated for younger women who wish to retain their fertility. Lifestyle modifications such as diet and exercise can modulate the risk of developing endometrial cancer as well as prevent recurrence and other comorbidities associated with obesity.

Entities:  

Mesh:

Year:  2017        PMID: 28561715     DOI: 10.1200/EDBK_175666

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  37 in total

1.  Long noncoding RNA H19 regulates HIF-1α/AXL signaling through inhibiting miR-20b-5p in endometrial cancer.

Authors:  He Zhu; Yue-Mei Jin; Xue-Man Lyu; Li-Mei Fan; Fei Wu
Journal:  Cell Cycle       Date:  2019-08-14       Impact factor: 4.534

2.  A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma.

Authors:  Jinhui Liu; Jian Yin; Yuanyuan Wang; Lixin Cai; Rui Geng; Mulong Du; Zihang Zhong; Senmiao Ni; Xiaohao Huang; Hao Yu; Jianling Bai
Journal:  Biol Proced Online       Date:  2022-07-15       Impact factor: 7.717

3.  The Characteristics of Real-time Transvaginal Sono-elastography in Endometrial Cancer.

Authors:  Chiou Li Ong; Lay Ee Chew; Nian-Lin Reena Han; Chin Chin Ooi; Yen Ching Yeo; Sung Hock Chew; Wai Loong Wong; Phua Hwee Tang; Sze Yiun Teo
Journal:  J Med Ultrasound       Date:  2022-01-06

4.  Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.

Authors:  Ajleeta Sangtani; Chen Wang; Amy Weaver; Nicole L Hoppman; Sarah E Kerr; Alexej Abyzov; Viji Shridhar; Julie Staub; Jean-Pierre A Kocher; Jesse S Voss; Karl C Podratz; Nicolas Wentzensen; John B Kisiel; Mark E Sherman; Jamie N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2019-11-28       Impact factor: 5.482

5.  Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer.

Authors:  Rajani Rai; Kathleen Gong Essel; Doris Mangiaracina Benbrook; Justin Garland; Yan Daniel Zhao; Vishal Chandra
Journal:  Cancers (Basel)       Date:  2020-05-18       Impact factor: 6.639

6.  MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.

Authors:  Qinyang Xu; Qiulin Ge; Yang Zhou; Bikang Yang; Qin Yang; Shuheng Jiang; Rongzhen Jiang; Zhihong Ai; Zhigang Zhang; Yincheng Teng
Journal:  EBioMedicine       Date:  2020-01-06       Impact factor: 8.143

Review 7.  Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer.

Authors:  Stephanie I Nuñez-Olvera; Dolores Gallardo-Rincón; Jonathan Puente-Rivera; Yarely M Salinas-Vera; Laurence A Marchat; Raúl Morales-Villegas; César López-Camarillo
Journal:  Front Oncol       Date:  2019-11-29       Impact factor: 6.244

8.  Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma.

Authors:  Jinhui Liu; Mengting Xu; Zhipeng Wu; Yan Yang; Shuning Yuan; Jianqiang Liang; Hongjun Zhu
Journal:  Front Mol Biosci       Date:  2021-05-19

9.  miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.

Authors:  Jian Ma; Da Li; Fan-Fei Kong; Di Yang; Hui Yang; Xiao-Xin Ma
Journal:  J Exp Clin Cancer Res       Date:  2018-02-01

Review 10.  A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs.

Authors:  Anh M Tran; Ghanbar Mahmoodi Chalbatani; Lea Berland; Mireia Cruz De Los Santos; Priyank Raj; Seyed Amir Jalali; Elahe Gharagouzloo; Cristina Ivan; Mihnea P Dragomir; George A Calin
Journal:  Front Cell Dev Biol       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.